BRCA1: A review of structure and putative functions

Disease Markers

Volumn 13, Issue 4, 1998, Pages 261-274

  Paterson, James W E ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

BRCA1; Cancer genetics; Cell cycle; Differentiation; DNA repair; Function; Molecular structure

Indexed keywords

BRCA1 PROTEIN;

BREAST CANCER; CANCER GENETICS; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CHEMICAL STRUCTURE; DNA DAMAGE; DNA REPAIR; EMBRYO CELL; GENE FUNCTION; GENE STRUCTURE; HUMAN; MOLECULAR CLONING; OVARY CANCER; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0031950790     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/1998/298530     Document Type: Review

References (107)

1. Abel, K.J., Xu, J.Z., Yin, G.Y., Lyons, R.H., Meisler, M.H., Weber, B.L. (1995). Mouse breal -localization, sequence-analysis and identification of evolutionarily conserved domains. Human Molecular Genetics, 4, 2265-2273.
2. Aprelikova, O., Kuthiala, A., Bessho, M., Ethier, S., Liu, E.T. (1996). BRCA1 protein level is not affected by peptide growth factors in MCF10A cell line. Oncogene, 13, 2487-2491.
3. Barker, D.F., Liu, X.D., Almeida, E.R.A. (1996). The BRCA1 and 1A1.3B promoters are parallel elements of a genomic duplication at 17q21. Genomics, 38, 215-222.
4. Baumann, P., Benson, F.E., West, S.C. (1996). Human Rud51 protein promotes ATP-Dependent homologous pairing and strand transfer reactions in vitro. Cell, 87, 757-766.
5. Beckmann, M.W., Picard, F., An, H.X., Vanroeyen, C.R.C., Dominik, S.L. Mosny, D.S., Schnurch, H.G., Bender, H.G., Niederacher, D. (1996). Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br. J. Cancer, 73, 1220-1226.
6. Borg, A., Zhang, Q.X., Johannsson, O., Olsson, H. (1994). High-frequency of allelic imbalance at the BRCA1 region on chromosome 17q in both familial and sporadic ductal breast carcinomas. Journal Of The National Cancer Institute, 86, 792-794.
7. Bork, P., Hofmann, K., Bucher, P., Neuwald, A.F., Altschul, S.F., Koonin, E.V. (1997). A superfamily of conserved domains in DNA damage responsive cell cycle checkpoint proteins. Faseb Journal, 11, 68-76.
8. Bowcock, A.M., Anderson, L.A., Friedman, L.S., Black, D.M., Osbornelawrence, S., Rowell, S.E., Hall, J.M., Solomon, E., King, M.C. (1993). THRA1 and D17S183 flank an interval of <4 cM for the breast ovarian cancer gene (BRCA1) on chromosome 17q21. Am. J. Hum. Genet., 52, 718-722.
9. Boyd, M., Harris, F., McFarlane, R., Davidson, H.R., Black, D.M. (1995). A human BRCA1 gene knockout. Nature, 375, 541-542.
10. Brunet, J.S., Narod, S.A., Tonin, P., Foulkes, W.D. (1997). BRCA1 mutations and survival in women with ovarian cancer. N. Engl. J. Med., 336, 1256
11. Burk, R.D. (1997). BRCA1 Mutations and survival in women with ovarian cancer. N. Engl. J. Med., 336, 1255
12. Callebaut, I., Mornon, J.P. (1997). From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Letters, 400, 25-30.
13. Cannistra, S.A. (1997). BRCA1 mutations and survival in women with ovarian cancer. N. Engl. J. Med., 336, 1254
14. Chapman, M.S., Verma, I.M. (1996). Transcriptional activation by BRCA1. Nature, 382, 678-679.
15. Chen, C.F., Li, S., Chen, Y.M., Chen, P.L., Sharp, Z.D., Lee, W.H. (1996). The nuclear localization sequences of the BRCA1 protein interact with the importin-subunit of the nuclear transport signal receptor. J. Biol. Chem., 271, 32863-32868.
16. Chen, K.S., Shepel, L.A., Haag, J.D., Heil, G.M., Gould, M.N. (1996). Cloning, genetic-mapping and expression studies of the rat Brca1 gene. Carcinogenesis, 17, 1561-1566.
17. Chen, Y.M., Chen, C.F., Riley, D.J., Allred, D.C., Chen, P.L., Vonhoff, D., Osborne, C.K., Lee, W.H. (1995). Aberrant subcellular-localization of BRCA1 in breast-cancer. Science, 270, 789-791.
18. Chen, Y.M., Chen, P.L., Riley, D.J., Lee, W.H., Allred, D.C., Osborne, C.K. (1996a). Location of BRCA1 in human breast and ovarian cancer cells - response. Science, 272, 125-126.
19. Chen, Y.M., Farmer, A.A., Chen, C.F., Jones, D.C., Chen, P.L., Lee, W.H. (1996b). BRCA1 is a 220-kda nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res., 56, 3168-3172.
20. Couch, F.J., Weber, B.L., Borresen, A.L., Brody, L., Casey, G., Devilee, P., Fitzgerald, M., Friend, S., Gayther, S., Goldgar, D., Murphy, P., Szabo, C., Weber, B., Wiseman, R., Anderson, T., Durocher, F., Ganguly, A., King, M.C., Lenoir, G., Narod, S., Olopade, O., Plummer, S., Ponder, B., Serova, O., Simard, J., Stratton, M., Warren, B. (1996). Mutations and polymorphisms in the familial early onset breast cancer (BRCA1) gene. Human Mutation, 8, 8-18.
21. Critchlow, S.E., Bowater, R.P., Jackson, S.P. (1997). Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV. Current Biology, 7, 588-598.
22. Crook, T., Crossland, S., Crompton, M.R., Osin, P., Gusterson, B.A. (1997). p53 mutations in BRCA1-associated familial breast cancer. Lancet, 350, 638-639.
23. Cropp, C.S., Champeme, M.H., Lidereau, R., Callahan, R. (1993). Identification of 3 regions on chromosome-17q in primary human breast carcinomas which are frequently deleted. Cancer Res., 53, 5617-5619.
24. Cropp, C.S., Nevanlinna, H.A., Pyrhonen, S., Stenman, U., Salmikangas, P., Albertsen, B., White, R., Callahan, R. (1994). Evidence for involvement of BRCA1 in sporadic breast carcinomas. Cancer Res., 54, 2548-2551.
25. Dobrovic, A., Simpfendorfer, D. (1997). Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res., 57, 3347-3350.
26. Easton, D.F., Bishop, D.T., Ford, D., Crockford, G.P., Breast Cancer Linkage Consortium (1993). Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet., 52, 678-701.
27. Eisinger, F., Stoppa-Lyonnet, D., Longy, M., Kerangueven, F., Noguchi, T., Bailly, C., Vincentsalomon, A., Jacquemier, J., Birnbaum, D., Sobol, H. (1996). Germ-line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res., 56, 471-474.
28. Ford, D., Easton, D.F., Bishop, D.T., Narod, S.A., Goldgar, D.E., Haites, N., Milner, B., Allan, L., Ponder, B.A.J., Peto, J., Smith, S., Stratton, M., Lenoir, G.M., Feunteun, J., Lynch, H., Arason, A., Barkardottir, R., Egilsson, V., Black, D.M., Kelsell, D., Spurr, N., Devilee, P., Cornelisse, C.J., Varsen, H., Birch, J.M., Skolnick, M., Santibanezkoref, M.S., Teare, D., Steel, M., Porter, D., Cohen, B.B., Carothers, A., Smyth, E., Weber, B., Newbold, B., Boehnke, M., Collins, F.S., Cannon-Albright, L.A., Goldgar, D. (1994). Risks of cancer in BRCA1-mutation carriers. Lancet, 343, 692-695.
29. Foster, K.A., Harrington, P., Kerr, J., Russell, P., Dicioccio, R.A., Scott, I.V., Jacobs, I., Chenevixtrench, G., Ponder, B.A.J., Gayther, S.A. (1996). Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res., 56, 3622-3625.
30. Foulkes, W.D., Black, D.M., Stamp, G.W.H., Solomon, E., Trowsdale, J. (1993). Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian-carcinoma. Int. J. Cancer, 54, 220-225.
31. Futreal, P.A., Soderkvist, P., Marks, J.R., Iglehart, J.D., Cochran, C., Barrett, J.C., Wiseman, R.W. (1992). Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res., 52, 2624-2627.
32. Futreal, P.A., Liu, Q.Y., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L.M., Haugenstrano, A., Swensen, J., Miki, Y., Eddinglon, K., McClure, M., Frye, C., Weaverfeldhaus, J., Ding, W., Gholami, Z., Soderkvist, P., Terry, L., Jhanwar, S., Berchuck, A., Iglehart, J.D., Marks, J., Ballinger, D.G., Barrett, J.C., Skolnick, M.H., Kamb, A., Wiseman, R. (1994). BRCA1 mutations in primary breast and ovarian carcinomas. Science, 266, 120-122.
33. Goldstein, A.M., Haile, R.W.C., Marazita, M.L., Paganinihill, A. (1987). A genetic epidemiologic investigation of breast cancer in families with bilateral breast cancer. I. segregation analysis. Journal Of The National Cancer Institute, 78, 911-918.
34. Gowen, L.C., Johnson, B.L., Latour, A.M., Sulik, K.K., Koller, B.H. (1996). Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nature Genetics, 12, 191-194.
35. Gudas, J.M., Nguyen, H., Li, T., Cowan, K.H. (1995). Hormone dependent regulation of BRCA1 in human breast cancer cells. Cancer Res., 55, 4561-4565.
36. Gudas, J.M., Li, T., Nguyen, H., Jensen, D., Rauscher, F.J., Cowan, K.H. (1996). Cell-cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth and Differentiation, 7, 717-723.
37. Hakem, R., de la Pompa, J.L., Elia, A., Potter, J., Mak, T.W. (1997). Partial rescue of Brca1 early embryonic lethality by p53 or p21 null mutation. Nature Genetics, 16, 298-302.
38. Hakem, R., de la Pompa, J.L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., Firpo, E., Hui, C.C., Roberts, J., Rossant, J., Mak, T.W. (1996). The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell, 85, 1009-1023.
39. Holt, J.T., Thompson, M.E., Szabo, C., Robinson-Benion, C., Artega, C.L., King, M.C., Jensen, R.A. (1996). Growth retardation and tumour inhibition by BRCA1. Nature Genetics, 12, 298-302.
40. Humphrey, J.S., Salim, A., Erdos, M.R., Collins, F.S., Brody, L.C., Klausner, R.D. (1997). Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing. Proc. Natl. Acad. Sci. USA, 94, 5820-5825.
41. Jensen, R.A., Thompson, M.E., Jetton, T.L., Szabo, C.I., van der Meer, R., Helou, B., Tronick, S.R., Page, D.L., King, M.C., Holt, J.T. (1996a). BRCA1 is secreted and exhibits properties of a granin. Nature Genetics, 12, 303-308.
42. Jensen, R.A., Thompson, M.E., Jetton, T.L., van der Meer, R., Helou, B., Arteaga, C.L., Page, D.L., Holt, J.T., Tronick, S.R., Gown, A.M., Skelly, M., Ostermeyer, B., Schieltz, D., Szabo, C.I., King, M.C. (1996b). BRCA1: Antibody specificity, functional motifs and secreted tumour suppressors - reply. Nature Genetics 13, 269-271.
43. Johannsson, O., Ranstam, J., Borg, A., Olsson, H. (1997). BRCA1 mutations and survival in women with ovarian cancer. N. Engl. J. Med., 336, 1255-1256.
44. Kelsell, D.P., Black, D.M., Bishop, D.T., Spurr, N.K. (1993). Genetic analysis of the BRCA1 region in a large breast ovarian family: refinement of the minimal region containing BRCA1. Human Molecular Genetics, 2, 1823-1828.
45. Kerangueven, F., Eisinger, F., Noguchi, T., Allione, F., Wargniez, V., Eng, C., Padberg, G., Theillet, C., Jacquemier, J., Longy, M., Sobol, H., Birnbaum, D. (1997). Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions. Oncogene, 14, 339-347.
46. Kinzler, K.W., Vogelstein, B. (1997). Gatekeepers and caretakers. Nature, 386, 761-762.
47. Koonin, E.V., Altschul, S.F., Bork, P. (1996). BRCA1: Antibody specificity, functional motifs and secreted tumour suppressors. Nature Genetics 13, 266-267.
48. Lakhani, S.R., Easton, D.F., Stratton, M.R., Storferlsser, A., Anderson, T.J., Farid, L.M., Gusterson, B.A., Jaquemier, J., Sloane, J.P., Venter, D., Vande Vijver, M.J., Bishop, D.T., Barkardottir, R.B., Bignon, Y.J., Cornelisse, C., Changclaude, J., Daly, P.A., Devilee, P., Egilsson, V., Ford, D., Goldgar, D., Haites, N., Hamann, U., Klijn, J.G.M., Lasset, C., Lenoir, G., Mcmanus, R., Neuhausen, S., Ormiston, W., Ponder, B.A.J., Peto, J., Steel, C.M., Stoppalyonnet, D., Smyth, E., Sobol, H., Spurr, N.K., Scott, R.J., Scherneck, S., Streuwing, J.P., Vasen, H., Weber, B. (1997). Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet, 349, 1505-1510.
49. Lane, D.P. (1994). P53 and human cancers. British Medical Bulletin 50, 582-599.
50. Lane, T.F., Deng, C.X., Elson, A., Lyu, M.S., Kozak, C.A., Leder, P. (1995). Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes and Development, 9, 2712-2722.
51. 2-M cell cycle control in human mammary epithelial cells. Cancer Res., 57, 3351-3355.
52. Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber B, Beller U, Lahad A and Halle D. (1997) Founder BRCA1 and BRCA2 mutations in Ashkenazi jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet., 60, 1059-1067.
53. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S.H., Giovanella, B.C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M.H., Parsons, R. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 1943-1947.
54. Lim, D.S., Hasty, P. (1996). A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol., 16, 7133-7143.
55. Lindblom, A., Skoog, L., Rotstein, S., Werelius, B., Larsson, C., Nordenskjold, M. (1993). Loss of heterozygosity in familial breast carcinomas. Cancer Res., 53, 4356-4361.
56. Lu, M.L., Conzen, S.D., Cole, C.N., Arrick, B.A. (1996). Characterization of functional messenger-RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells. Cancer Res., 56, 4578-4581.
57. Ludwig, T., Chapman, D.L., Papaioannou, V.E., Efstratiadis, A. (1997). Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/ Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes and Development 11, 1226-1241.
58. Malone, K.E., Daling, J.R., Weiss, N.S., Mcknight, B., White, E., Voigt, L.F. (1996). Family history and survival of young women with invasive breast carcinoma. Cancer, 78, 1417-1425.
59. Marcus, J.N., Watson, P., Page, D.L., Narod, S.A., Lenoir, G.M., Tonin, P., Linderstephenson, L., Salerno, G., Conway, T.A., Lynch, H.T. (1996). Hereditary breast cancer - pathobiology. prognosis, and BRCA1 and BRCA2 gene linkage. Cancer, 77, 697-709.
60. Marks, J.R., Huper, G., Vaughn, J.P., Davis, P.L., Morris, J., McDonnell, D.P., Wiseman, R.W., Futreal, P.A., Iglehart, J.D. (1997). BRCA1 expression is not directly responsive to estrogen. Oncogene, 14, 115-121.
61. Marquis, S.T., Rajan, J.V., Wynshawboris, A., Xu, T.J., Yin, G.Y., Abel, K.J., Weber, B.L., Chodosh, L.A. (1995). The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nature Genetics, 11, 17-26.
62. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., Liu, Q.Y., Cochran, C., Bennett, L.M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugenstrano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P.K., Norris, F.H., Helvering, L., Morrison, P., Rosteck, P., Lai, M. Barrett, J.C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., Skolnick, M.H. (1994). A strong candidate for the breast and ovarian-cancer susceptibility gene BRCA1. Science, 266, 66-71.
63. Modan, B. (1997). BRCA1 mitations and survival in women with ovarian cancer. N. Engl. J. Med., 336, 1255
64. Monteiro, A.N.A., August, A., Hanafusa, H. (1996). Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA, 93, 13595-13599.
65. Munn, K.E., Walker, R.A., Menasce, L., Varley, J.M. (1996). Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast. Br. J. Cancer, 73, 636-639.
66. Neuhausen, S.L., Swensen, J., Miki, Y., Liu, Q., Tavtigian, S., Shattuck-Eidens, D., Kamb, A., Hobbs, M.R., Gingrich, J., Shizuya, H., Kim, U.J., Cochran, C., Futreal, P.A., Wiseman, R.W., Lynch, H.T., Tonin, P., Narod, S., Cannon-Albright, L., Skolnick, M.H., Goldgar, D.E. (1994). A P1-based physical map of the region from D17s776 to D17s78 containing the breast cancer susceptibility gene BRCA1. Human Molecular Genetics, 3, 1919-1926.
67. Neuhausen, S.L., Marshall, C.J. (1994). Loss of heterozygosity in familiar tumors from 3 BRCA1-linked kindreds. Cancer Res., 54, 6069-6072.
68. Newman, B., Austin, M.A., Lee, M., King, M.C. (1988). Inheritance of human-breast cancer -evidence for autosomal dominant transmission in high-risk families. Proc. Natl. Acad. Sci. USA, 85, 3044-3048.
69. Papp, J., Csokay, B., Bosze, P., Zalay, Z., Toth, J., Ponder, B., Olah, L. (1996). Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas. Br. J. Cancer, 74, 1592-1597.
70. Petrijbosch, A., Peelen, T., Vanvliet, M., vanEijk, R., Olmer, R., Drusedau, M., Hogervorst, F.B.L., Hageman, S., Arts, P.J.W., Ligtenberg, M.J.L., Meijersheijboer, H., Klijn, J.G.M., Vasen, H.F.A., Cornelisse, C.J., vantVeer, L.J., Bakker, E., Vanommen, G.J.B., Devilee, P. (1997). BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nature Genetics, 17, 341-345.
71. Phillips, K.W., Goldsworthy, S.M., Bennett, L.M., Brownlee, H.A., Wiseman, R.W., Davis, B.J. (1997). Brca1 is expressed independently of hormonal stimulation in the mouse ovary. Laboratory Investigation, 76, 419-425.
72. Porter, D.E., Dixon, M. Smyth, E., Steel, C.M. (1993). Breast-cancer survival in BRCA1 carriers. Lancet, 341, 184-185.
73. Puget, N., Torchard, D., SerovaSinilnikova, O.M., Lynch, H.T., Feunteun, J., Lenoir, G.M., Mazoyer, S. (1997). A 1-kb alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res., 57, 828-831.
74. Rajan, J.V., Wang, M. Marquis, S.T., Chodosh, L.A. (1996). Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial-cells. Proc. Natl. Acad. Sci. USA, 93, 13078-13083.
75. Rao, V.N., Shao, N.S., Ahmad, M., Reddy, E.S.P. (1996). Antisense RNA to the putative tumor-suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene, 12, 523-528.
76. Rubin, S.C., Benjamin, I., Behbakht, K., Takahashi, H., Morgan, M.A., Livolsi, V.A., Berchuck, A., Muto, M.G., Garber, J.E., Weber, B.L., Lynch, H.T., Boyd, J. (1996). Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N. Engl. J. Med., 335, 1413-1416.
77. Rubin, S.C. (1997). BRCA1 mutations and survival in women with ovarian cancer-reply. N. Engl. J. Med., 336, 1256-1257.
78. Ruffner, H., Verma, I.M. (1997). BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc. Natl. Acad. Sci. USA, 97, 7138-7143.
79. Sato, T., Akiyama, F., Sakamoto, G., Kasumi, F., Nakamura, Y. (1991). Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res., 51, 5794-5799.
80. Scully, R., Ganesan, S., Brown, M., Decaprio, J.A., Cannistra, S.A., Feunteun, J., Schnitt, S., Livingston, D.M. (1996). Location of BRCA1 in human breast and ovarian cancer cells. Science, 272, 123-125.
81. Scully, R., Anderson, S.F., Chao, D.M., Wei, W.J., Ye, L.Y., Young, R.A., Livingston, D.M., Parvin, J.D. (1997a). BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. USA, 94, 5605-5610.
82. Scully, R., Chen, J., Ochs, R.L., Keegan, K., Hoekstra, M., Feunteun, J., Livingston, D.M. (1997b). Dynamic changes of BRCA1 subnuclear location and Phosphorylation state are initiated by DNA damage. Cell, 90, 425-435.
83. Scully, R., Chen, J.J., Plug, A., Xiao, Y.H., Weaver, D., Feunteun, J., Ashley, T., Livingston, D.M. (1997c). Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265-275.
84. Shao, N.S., Chai, Y.L., Shyam, E., Reddy, P., Rao, N.V. (1996). Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene, 13, 1-7.
85. Sharan, S.K., Wims, M., Bradley, A. (1995). Murine brca1 - sequence and significance for human missense mutations. Human Molecular Genetics, 4, 2275-2278.
86. Smith, S.A., Easton, D.F., Evans, D.G.R., Ponder, B.A.J. (1992). Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature, Genetics 2, 128-131.
87. Sobol, A., Stoppa-Lyonnet, D., Bressacdepaillerets, B., Peyrat, J.P., Kerangueven, F., Janin, N., Noguchi, T., Eisinger, F., Guinebretiere, J.M., Jacquemier, J., Birnbaum, D. (1996). Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers. Cancer Res., 56, 3216-3219.
88. WAF1/CIP1. Nature, 389, 187-190.
89. Spillman, M.A., Bowcock, A.M. (1996). BRCA1 and BRCA2 messenger-RNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene, 13, 1639-1645.
90. Sung, P., Robberson, D.L. (1995). DNA strand exchange mediated by a RAD51-ssDNA nucleoprotein filament with polarity opposite to that of RecA. Cell, 82, 453-461.
91. Szabo, C.I., King, M.C. (1995). Inherited breast and ovarian-cancer. Human Molecular Genetics, 4, 1811-1817.
92. Tait, D.L., Obermiller, P.S., RedlinFrazier, S., Jensen, R.A., Welcsh, P., Dann, J., King, M.C., Johnson, D.H., Holt, J.T. (1997). A phase I trial of retroviral BRCA1 sv gene therapy in ovarian cancer. Clinical Cancer Research, 3, 1959-1968.
93. Takahashi, H., Chin, H.C., Bandera, C.A., Behbakht, K., Liu, P.C., Couch, F.J., Weber, B.L., Livolsi, V.A., Furusato, M., Rebane, B.A., Cardonick, A., Benjamin, I., Morgan, M.A., King, S.A., Mikuta, J.J., Rubin, S.C., Boyd, J. (1996). Mutations of the BRCA2 gene in ovarian carcinomas. Cancer Res., 56, 2738-2741.
94. Thakur, S., Zhang, H.B., Peng, Y., Le, H., Carroll, B., Ward, T., Yao, J., Farid, L.M., Couch, F.J., Wilson, R.B., Weber, B.L. (1997). Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell. Biol., 17, 444-452.
95. Thomas, J.E., Smith, M., Rubinfeld, B., Gutowski, M., Beckmann, R.P., Polakis, P. (1996). Subcellular localization and analysis of apparent 180-kda and 220-kda proteins of the breast-cancer susceptibility gene, BRCA1. J. Biol. Chem., 271, 28630-28635.
96. Thompson, M.E., Jensen, R.A., Obermiller, P.S., Page, D.L., Holt, J.T. (1995). Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast-cancer progression. Nature Genetics, 9, 444-450.
97. Tsuzuki, T., Fujii, Y., Sakumi, K., Tominaga, Y., Nakao, K., Sekiguchi, M., Matsushiro, A., Yoshimura, Y., Morita, T. (1996). Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. USA, 93, 6236-6240.
98. Vaughn, J.P., Davis, P.L., Jarboe, M.D., Huper, G., Evans, A.C., Wiseman, R.W., Berchuck, A., Iglehart, J.D., Futreul, P.A., Marks, J.R. (1996). BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth and Differentiation, 7, 711-715.
99. Wang, H., Shao, N., Ding, Q.M., Cui, J.Q., Reddy, E.S.P., Rao, V.M. (1997). BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phophoproteins that associate with E2F, cyclins and cyclin dependent kinsases. Oncogene, 15, 143-157.
100. Whitmore, E. (1997). BRCA1 mutations and survival in women with ovarian cancer. N. Engl. J. Med., 336, 1254-1255.
101. Wilson, C.A., Payton, M.N., Elliott, G.S., Buaas, F.W., Cajulis, E.E., Grosshans, D., Ramos, L., Reese, D.M., Slamon, D.J., Calzone, F.J. (1997). Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta 11b. Oncogene, 14, 1-16.
102. Wooster, R., Neuhausen, S.L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., Fields, P., Marshall, G., Narod, S., Lenoir, G.M., Lynch, H., Feunteun, J., Devilee, P., Cornelisse, C.J., Menko, F.H., Daly, P.A., Ormiston, W., Mcmanus, R., Pye, C., Lewis, C.M., Cannon-Albright, L.A., Peto, J., Ponder, B.A.J., Skolnick, M.H., Easton, D.F., Goldgar, D.E., Stratton, M.R. (1994). Localization of a breast-cancer susceptibility gene. BRCA2, to chromosome 13q12-13. Science, 265, 2088-2090.
103. Xu, C.F., Brown, M.A., Chambers, J.A., Griffiths, B., Nicolai, H., Solomon, E. (1995). Distinct transcription start sites generate 2 forms of BRCA1 messenger-RNA. Human Molecular Genetics, 4, 2259-2264.
104. Xu, C.F., Chambers, J. A., Solomon, E. (1997). Complex regulation of the BRCA1 gene. J. Biol. Chem., 272, 20994-20997.
105. Yamamoto, A., Taki, T., Yagi, H., Habu, T., Yoshida, K., Yoshimura, Y., Yamamoto, K., Matsushiro, A., Nishimune, Y., Morita, T. (1996). Cell-cycle dependent expression of the mouse Rad51 gene in proliferating cells. Molecular and General Genetics, 251, 1-12.
106. Zabludoff, S.D., Wright, W.W., Harshman, K., Wold, B.J. (1996). BRCA1 mRNA is expressed highly during meiosis and spermiogenesis but not during mitosis of male germ-cells. Oncogene, 13, 649-653.
107. BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells. Oncogene, 14, 2863-2869.